Persistent Head and Neck Cancer Following First-Line Treatment

<i>Background:</i> Following first-line treatment of head and neck cancer (HNC), persistent disease may require second-line treatment. <i>Methods:</i> All patients with HNC treated between 2008 and 2016 were included. Second-line treatment modalities and survival of patients...

Full description

Bibliographic Details
Main Authors: Teresa Bernadette Steinbichler, Madeleine Lichtenecker, Maria Anegg, Daniel Dejaco, Barbara Kofler, Volker Hans Schartinger, Maria-Therese Kasseroler, Britta Forthuber, Andrea Posch, Herbert Riechelmann
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/10/11/421